Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence

Sellers, Edward M., Toneatto, Tony, Romach, Myroslava K., Somer, Gail R., Sobell, Linda C., Sobell, Mark B.·1994·Alcoholism: Clinical and Experimental Research

Abstract

Medications that act on the serotonergic system have been found to be of benefit in the treatment of alcohol‐dependent individuals. In a randomized, placebo‐controlled study, the efficacy of 6 weeks of ondansetron, a 5‐HT 3 antagonist (0.25 mg bid or 2.0 mg bid), in the treatment of 71 nonseverely alcohol‐dependent males was tested. The results showed reduction of drinking differences were steadily increasing toward the end of the treatment period approached significance at week 7 in the 0.25 mg group (p= 0.06). Twice as many patients in this group showed >2 standard deviations decrease in drinking compared with the other groups. When patients drinking >10 drinks/drinking day at baseline (n= 11) were excluded from the analysis, significant group differences were found at both treatment and follow‐up, with the lower ondansetron dose producing the greatest reduction from baseline (i.e., 2.8 standard drinks; –35% compared with baseline and –21% compared with placebo; p < 0.02–0.001). Within this group, there was an almost 4‐fold greater number of patients showing a clinically meaningful decrease in drinking. Lower baseline drinking and higher level of education were significant and strong predictors of drinking reduction during treatment. Ondansetron was very well tolerated; hence, further long‐term studies with 5‐HT 3 antagonists alone or in combination with other treatment components may offer promise for treatment of alcoholism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1530-0277.1994.tb00054.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 185

Metadata

Authors
Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., & Sobell, M. B.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
1994-08
Volume
18
Issue
4
Pages
879-885
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W2150602253
Cited by
185
References
3
FWCI
9.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence. https://app.cochat.ai/papers/10.1111/j.1530-0277.1994.tb00054.x
The paper
Sellers, E. M., Toneatto, T., Romach, M. K., Somer, G. R., Sobell, L. C., & Sobell, M. B. (1994). Clinical Efficacy of the 5‐HT3 Antagonist Ondansetron in Alcohol Abuse and Dependence. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.1994.tb00054.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.